FDA Panel Recommends Against OK'ing Blue-Dye Opioid
A U.S. Food and Drug Administration advisory panel on Wednesday overwhelmingly voted not to approve an opioid painkiller that would discourage abuse by staining would-be users with blue dye if they...To view the full article, register now.
Already a subscriber? Click here to view full article